T. Rowe Price Investment Management, Inc.
Position in BSX — Boston Scientific Corp
CIK 1897612
BALTIMORE, MD
Position in BSX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$297,748
New position
Shares Held
4,745
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Medical Devices
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $654,461,135 across 13 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
1,512,160 | $230,226,360 | |
| 2 | NEOG |
Neogen Corp
|
9,333,261 | $83,906,016 | |
| 3 | HAE |
Haemonetics Corp
|
1,101,371 | $82,602,825 | |
| 4 | PRCT |
PROCEPT BioRobotics Corp
|
3,265,704 | $73,739,596 | |
| 5 | ALMR |
Alamar Biosciences, Inc.
|
2,202,597 | $59,668,352 | |
| 6 | QDEL |
QuidelOrtho Corp
|
1,743,563 | $30,547,223 | |
| 7 | IRMD |
Iradimed Corp
|
318,680 | $30,453,060 | |
| 8 | STE |
STERIS plc
|
118,752 | $25,005,608 |
All Filings in BSX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $297,748 | 4,745 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||